In light of this, we utilized gastroscopic tissues from GC patients who had not been treated with ICI for mIHC staining, aiming to categorize patients based on varying ratios of Pygo2+ CD8+ T cells, and then screened out GC patients with different Pygo2+ CD8+ T cell ratios (Figure 5A). This evidence concerns the gene PYGO2 and gastric cancer.